Al Hansen is listed as a director on 3 SEC Form D filings by 1 issuer between Dec 2009 and Aug 2011: BIOJECT MEDICAL TECHNOLOGIES INC (Tigard, OR — other health care — 2009–2011; $1.2M reported sold to 6 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Christine Farrell (3 shared filings), David S. Tierney (3 shared filings), Edward Flynn (3 shared filings), Jerald Cobbs (3 shared filings), Mark Logomasini (3 shared filings) and 2 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Al. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Al Hansen and found 3 differences, 1 worth asking the sponsor about: Regulator action naming a team member: Bioject Medical Technologies, Inc. Black Castle Developments Holdings Inc. (n/k/a ingXabo Corporation) Catalyst Resource Group, Inc. SSI International, Ltd. Strike Axe, Inc. Viper Powersports, Inc. (Dec 22, 2015); and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.